Cargando…
Comparison of the Use of a Physiologically Based Pharmacokinetic Model and a Classical Pharmacokinetic Model for Dioxin Exposure Assessments
In epidemiologic studies, exposure assessments of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) assume a fixed elimination rate. Recent data suggest a dose-dependent elimination rate for TCDD. A physiologically based pharmacokinetic (PBPK) model, which uses a body-burden–dependent elimination rate, was...
Autores principales: | Emond, Claude, Michalek, Joel E., Birnbaum, Linda S., DeVito, Michael J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314902/ https://www.ncbi.nlm.nih.gov/pubmed/16330344 http://dx.doi.org/10.1289/ehp.8016 |
Ejemplares similares
-
Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD
por: Emond, Claude, et al.
Publicado: (2006) -
Exposure assessment to dioxins from the use of tampons and diapers.
por: DeVito, Michael J, et al.
Publicado: (2002) -
A Physiologically Based Pharmacokinetic (PBPK) Modeling Framework for Mixtures of Dioxin-like Compounds
por: Liu, Rongrui, et al.
Publicado: (2022) -
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
por: Carlander, Ulrika, et al.
Publicado: (2016) -
Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments
por: Emond, Claude, et al.
Publicado: (2022)